Gene Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
62
NCT06765980
A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 28, 2025
Completion: Dec 15, 2027
Loading map...